SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041090
Filing Date
2019-11-06
Accepted
2019-11-06 16:40:23
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zfgn-10q_20190930.htm 10-Q 2470724
2 EX-31.1 zfgn-ex311_8.htm EX-31.1 7979
3 EX-31.2 zfgn-ex312_7.htm EX-31.2 7983
4 EX-32.1 zfgn-ex321_6.htm EX-32.1 12985
  Complete submission text file 0001564590-19-041090.txt   7745469

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT zfgn-20190930.xml EX-101.INS 1747441
6 XBRL TAXONOMY EXTENSION SCHEMA zfgn-20190930.xsd EX-101.SCH 45462
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zfgn-20190930_cal.xml EX-101.CAL 57795
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zfgn-20190930_def.xml EX-101.DEF 117406
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE zfgn-20190930_lab.xml EX-101.LAB 372146
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zfgn-20190930_pre.xml EX-101.PRE 273674
Mailing Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108
Business Address 3 CENTER PLAZA SUITE 610 BOSTON MA 02108 617-622-4003
ZAFGEN, INC. (Filer) CIK: 0001374690 (see all company filings)

IRS No.: 203857670 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36510 | Film No.: 191196894
SIC: 2834 Pharmaceutical Preparations